| Thomas Toan Trinh, MD | |
|
4035 Sw Mercantile Dr, Suite 103, Lake Oswego, OR 97035 | |
| (503) 675-7495 | |
| (503) 675-7496 |
| Full Name | Thomas Toan Trinh |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 4035 Sw Mercantile Dr, Lake Oswego, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366526147 | NPI | - | NPPES |
| MD21038 | Other | OR | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD21038 (Oregon) | Primary |
| Entity Name | Northwest Medical Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982861902 PECOS PAC ID: 6204809304 Enrollment ID: O20040817000733 |
News Archive
The Swedish MedTech company Lumito is at its final stages of developing a new and unique method for digital tissue diagnostics that streamlines diagnosis and improves accuracy.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
"Child marriage is a one-way ticket to a life of poverty, illiteracy and powerlessness for girls and the international community needs to take urgent action to stop it," according to an analysis published Friday by former British Prime Minister Gordon Brown, the Guardian reports.
Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2012. The final results for the three and twelve months ended May 31, 2012 will be made available to the public with the filing of Biomet's Form 10-K for fiscal year 2012 and will include the finalization of a non-cash goodwill and intangible asset impairment charge as further described below and certain income tax accounts.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Toan Trinh, MD 4035 Sw Mercantile Dr, Suite 103, Lake Oswego, OR 97035 Ph: (503) 675-7495 | Thomas Toan Trinh, MD 4035 Sw Mercantile Dr, Suite 103, Lake Oswego, OR 97035 Ph: (503) 675-7495 |
News Archive
The Swedish MedTech company Lumito is at its final stages of developing a new and unique method for digital tissue diagnostics that streamlines diagnosis and improves accuracy.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
"Child marriage is a one-way ticket to a life of poverty, illiteracy and powerlessness for girls and the international community needs to take urgent action to stop it," according to an analysis published Friday by former British Prime Minister Gordon Brown, the Guardian reports.
Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2012. The final results for the three and twelve months ended May 31, 2012 will be made available to the public with the filing of Biomet's Form 10-K for fiscal year 2012 and will include the finalization of a non-cash goodwill and intangible asset impairment charge as further described below and certain income tax accounts.
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 5 days ago
Laura Lei Zhong Gaff, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4004 Kruse Way Pl Ste 300, Lake Oswego, OR 97035 Phone: 503-216-1500 | |
James Clive Chesnutt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4811 Meadows Rd Ste 101, Lake Oswego, OR 97035 Phone: 360-254-6161 Fax: 360-449-1146 | |
Dr. Walter Ray Hardin, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6 Centerpointe Dr Ste 200, Lake Oswego, OR 97035 Phone: 503-797-2268 | |
Dr. David W Selby, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16463 Boones Ferry Rd Ste 100, Lake Oswego, OR 97035 Phone: 503-635-1350 Fax: 503-635-8470 | |
Dr. Josh Gepner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 412 A Ave Ste 200, Lake Oswego, OR 97034 Phone: 503-635-2496 Fax: 503-635-2497 | |
Michael Zimmerman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6 Centerpointe Dr Ste 200, Lake Oswego, OR 97035 Phone: 503-797-2273 Fax: 503-234-8155 | |
Herbert H Lim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4015 Mercantile Dr Ste 200, Lake Oswego, OR 97035 Phone: 503-216-1500 |